Switch to:
More From Other Websites
Francis Chou Comments on Valeant Mar 24 2017
Chou Opportunity Fund 4th Quarter Message to Shareholders Mar 24 2017
Bausch & Lomb Continues to be Key Growth Driver for Valeant Mar 24 2017
Valeant’s Diversified Products Revenue May Drop in 2017 Mar 24 2017
Valeant Pharmaceuticals is Developing its Sales Force Mar 24 2017
A Safer Way to Play Valeant and Community Health Mar 23 2017
'Female Viagra' founder: GOP health bill would hurt the 'sexual revolution' Mar 23 2017
Valeant CEO Compensation Revealed, Shares Climb Mar 23 2017
Siliq May be a Strong Growth Driver for Valeant in 2017 Mar 23 2017
Bill Ackman Is Back at the Sohn Investment Conference This Year Mar 23 2017
Valeant: Room to Move? Mar 23 2017
New Product Launches May Boost Valeant’s Dermatology Revenue Mar 23 2017
Valeant’s Dermatology Business Felt Pricing Pressure in 2016 Mar 23 2017
Valeant Closes Down Slightly After Completing Refi Mar 22 2017
Valeant Rearranges Deck Chairs Mar 22 2017
Relistor May Be Solid Growth Opportunity for Valeant in 2017 Mar 22 2017
Valeant's IBS-D Drug Could See Competition with FDA Changes Mar 22 2017
Zacks Investment Ideas feature highlights: Nasdaq Biotechnology Index, Gilead, Valeant Pharma,... Mar 22 2017
Xifaxan Expected to Witness Robust Growth in 2017 Mar 22 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK